TherapeuticsMD, Inc.
- Stock
- Ticker TXMD
- ISIN US88338N2062
- Nasdaq
Performance, volatility and drawdowns of TherapeuticsMD, Inc. since 11/2016, with distributions reinvested and calculated in US dollars. As of 20 Nov 2026.
Performance
$10,000 grew to $49. Global equities (VT): $29,042.
Distributions reinvested, before taxes and brokerage costs. Dashed: Global equities (VT) for comparison.
Declines from the peak
Lowest point −99.8% in 03/2025, measured from the peak in 04/2017. The old peak has not been reached again yet.
Financial statements
Amounts in $ millions from filings with the SEC, earnings per share in $; fourth quarter and quarterly cash flow derived from year-to-date figures
| Quarter end | 12/2024 | 03/2025 | 06/2025 | 09/2025 | 12/2025 | 03/2026 | 06/2026 | 09/2026 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | 0.7 | 0.4 | 1.0 | 0.8 | 0.9 | 0.7 | 0.9 | 1.3 |
| Operating income | -0.7 | -1.3 | -0.7 | -0.9 | -1.6 | -0.7 | -0.8 | -0.5 |
| EBITDA | -0.6 | -1.2 | -0.6 | -0.8 | -1.5 | -0.6 | -0.7 | -0.4 |
| Net income | 0.3 | -0.7 | 0.6 | 0.2 | -0.6 | 0.1 | 0.2 | 0.5 |
| Earnings per share | 0.02 | -0.06 | 0.05 | 0.01 | -0.05 | 0.01 | 0.01 | 0.04 |
| Balance sheet | ||||||||
| Total assets | 39 | 38 | 39 | 39 | 38 | 38 | 38 | 38 |
| Liabilities | 11 | 11 | 11 | 11 | 11 | 11 | 10 | 10 |
| Equity | 27 | 27 | 27 | 27 | 27 | 27 | 27 | 28 |
| Cash | 5.1 | 5.7 | 6.1 | 7.1 | 7.5 | 8.4 | 9.2 | 10 |
| Cash flow | ||||||||
| Operating cash flow | 0.0 | 0.7 | 0.4 | 1.0 | 0.4 | 0.9 | 0.8 | 1.3 |
| Free cash flow | 0.0 | 0.7 | 0.4 | 1.0 | 0.4 | 0.9 | 0.8 | 1.3 |
Value it:DCF calculatorMultiples calculator
Annual returns
Best year 2025 at +89.5%, weakest 2021 at −70.6%. 2 of 9 full years were positive. * partial year.
Quarterly reports
Filing date with the SEC and earnings per share of the quarter
| Day | Earnings per share |
|---|---|
| 13 Nov 2026 | $0.04 |
| 11 Aug 2026 | $0.01 |
| 12 May 2026 | $0.01 |
| 30 Mar 2026 | −$0.05 |
| 12 Nov 2025 | $0.01 |
| 12 Aug 2025 | $0.05 |
| 13 May 2025 | −$0.06 |
| 27 Mar 2025 | $0.02 |
| 12 Aug 2024 | −$0.09 |
| 29 Mar 2024 | −$0.07 |
Key metrics
Metrics of 15 Nov 2026; P/E, P/B, P/S, market cap and dividend yield at the last close.
Valuation
- Market cap
- €18m
- Market cap in trading currency
- $19.8m
- Enterprise value
- $9.35m
- P/E
- 171.0
- P/S
- 5.28
- P/B
- 0.72
- EV/Sales
- 2.50
- EV/EBITDA
- –
- Earnings yield
- 0.6%
- FCF yield
- 17.0%
Results (last four quarters)
- Revenue
- $3.75m
- Gross profit
- –
- EBITDA
- −$3.19m
- Net income
- $122,000
- Earnings per share
- $0.01
- Revenue per share
- $0.32
- Revenue growth
- +60.6%
- Earnings growth
- +223.0%
Profitability
- Gross margin
- –
- Operating margin
- -95.3%
- Net margin
- 3.3%
- Return on equity
- 0.4%
- Return on assets
- 0.3%
Balance sheet and cash flow
- Cash
- $10.4m
- Cash per share
- $0.90
- Financial debt
- –
- Debt/equity %
- –
- Current ratio
- 3.32
- Book value per share
- $2.39
- Operating cash flow
- $3.37m
- Free cash flow
- $3.37m
Dividend
- Dividend yield
- 0.00%
- Dividend (12 months)
- $0.00
- Yield (12 months)
- 0.00%
- Payout ratio
- 0%
- Ex-dividend date
- –
Shares and trading
- Shares outstanding
- 11.6m
- Volume
- 25,043
- Avg. volume 3 months
- 23,838
- Relative volume
- 1.0
Price and technicals
- Price
- $1.71
- 1 day
- −5.5%
- 52-week high
- $2.77
- 52-week low
- $1.46
- Distance to 52-week high
- −38.3%
- Distance to 52-week low
- +17.1%
- Distance to 50-day line
- −11.6%
- Distance to 200-day line
- −17.5%
- RSI (14)
- 40
- Volatility 1M
- 53.7%
Performance
- 1 week
- −8.6%
- 1 month
- −7.6%
- 3 months
- −17.4%
- 6 months
- −19.3%
- YTD
- +4.9%
- 1 year
- +3.6%
Dates
- Fiscal year end
- 31 Dec 2025
- Most recent quarter
- 30 Sep 2026
Frequently asked questions
How has TXMD performed since 11/2016?
$10,000 grew to $49 by 20 Nov 2026, which is −41.2% per year. Distributions are reinvested; taxes and brokerage costs are not deducted.
How volatile is TXMD?
Volatility was 71.6% per year, measured on monthly returns. The largest decline from a peak was −99.8%, with the low in 03/2025.
How does TXMD compare with a broad equity ETF?
Over the same period Global equities (VT) returned +11.3% per year at 15.1% volatility, TXMD returned −41.2% at 71.6%. The correlation of monthly returns was 0.28; 1 would mean they moved in lockstep.
Which currency are the figures in?
In US dollars, the currency of the US listing.